INTRODUCTION
Factor I is one of the six serine proteinases (SPs) involved in the activation and control of the complement system of immune defence. Its function is to regulate the formation of the C3 convertases by proteolytic degradation of the activated complement components C4b and C3b (Hourcade et al., 1989) , and for this reason was earlier known as 'C3b/C4b inactivator' (Crossley, 1981) . For cleavage of C3b (or C3u) and C4b (or C4u), a cofactor protein must first form a complex with C3b or C4b. Factor H acts as a cofactor for the cleavage by factor I of C3b, whereas C4b-binding protein (C4BP) is a requisite cofactor for C4b degradation, again enhancing cleavage by factor I of the a' chain (Fujita et al., 1978; Gigli et al., 1979) . The cell-surface protein complement receptor type 1 (CR1) is another cofactor for both C3b and C4b degradation that involves factor I (Fearon, 1979; Medof et al., 1982) ; another is the membrane cofactor protein (Hourcade et al., 1989) . C4b is cleaved twice by factor I to form C4c and C4d, whereas C3b is cleaved twice in the a' chain to form C3f and iC3b. Further breakdown of iC3b to C3dg plus C3c may be mediated by factor I, with CR1 (only) as cofactor, but it is possible that another protease may mediate this degradation step (Becherer et al., 1989) . Factor I is unusual in that no proenzymic form exists and that it is not normally inhibited by any known protein proteinase inhibitor, nor by the commonly used SP inhibitors such as di-isopropyl fluorophosphate, benzamidine and phenylmethanesulphonyl fluoride (Crossley and Porter, 1980; Ekdahl et al., 1990) .
The complete cDNA-derived amino acid sequence of factor I has been established (Catterall et al., 1987; Goldberger et al., 1987) . Factor I consists of a heavy chain (polypeptide M, 35400) data were not noticeably dependent on the solute-solvent contrast, whereas the RXS data showed a small dependence. The maximum dimension of factor I was determined to be 12.8 nm from the RG and RXS data, and 14-15 nm from the X-ray and neutron distance distribution functions. This length is too short to account for a linear arrangement of the domains in factor I. Small sphere models were developed for factor I in which the largest domain was modelled from the crystal structure for f,-trypsin. The attachment of either an elliptical cylinder or a twoarmed V-shaped structure to this domain to represent the remaining four small domains gave good scattering curve-fits for factor I, and were compatible with experimental sedimentation coefficients. The non-extended domain models for factor I imply that the steric accessibility of each domain will be reduced, and this may be important for its functional activity. and a light chain (polypeptide Mr 27600), each of which has three putative N-linked glycosylation sites. The light chain (243 amino acids) consists entirely of an SP domain. Starting from the N-terminus, the heavy chain (318 amino acids) contains one region of sequence similarity known as the factor I module (FIM), another one corresponding to a CD5-like domain approx. 100 residues long, and two more to the class-A low-densitylipoprotein receptor (LDLr) domain (Haefliger et al., 1989; DiScipio and Hugli, 1989; Freeman et al., 1990; Schneider, 1989; Reid and Day, 1989; Sim et al., 1993) . Another report suggesting a 60-residue similarity to the short consensus/ complement repeat is not statistically valid (Goldberger et al., 1987; Haefiiger et al., 1989; Sim et al., 1993) . Another suggestion that residues 12-59 of factor I exhibited similarity with the epideimal-growth-factor domain has now been superseded by the recognition of the FIM as a distinct structural motif (Catterall et al., 1987; Reid and Day, 1989) . Of particular interest is that the FIM and LDLr domains occur also in several of the late complement components that form the lytic membrane-attack complex.
Knowledge of the arrangement of the five domains recognized to date in the factor I sequence is essential for any proposed molecular mechanism for the function of factor I in the complement system. Surprisingly little structural information is available on factor I, apart from sedimentation coefficient and electron-microscopic data (Cooper, 1975; DiScipio, 1992 (Perkins, 1988a,b) . Use of the known crystal structures for the common SPs is a useful constraint on the interpretation of the scattering data [see the accompanying paper ]. Here we determine the molecular dimensions of factor I in conditions close to physiological, and assess possible arrangements for the five domains within this structure. The structure of factor I can be compared with similar models for those of C4 and C4BP in order to assess the nature of the possible interactions between these proteins.
MATERIALS AND METHODS
Protein purification of factor I Factor I was prepared from outdated human plasma (Regional Blood Transfusion Service, Oxford, U.K.), by the method of Hsiung et al. (1982) as modified by Sim et al. (1993) . This procedure consists of extraction of factor I from plasma by passage over a column of MRC-OX21 [mouse anti-(human factor I) monoclonal antibody] covalently bound to Sepharose. Factor I was eluted from the antibody column with a pH 11.5 wash or by the use of 3 M MgCl2 at pH 6.8 and was subsequently purified to homogeneity by gel filtration on Sephacryl S-200. As described for C3 and its fragments (Perkins and Sim, 1986) , factor I was initially concentrated to about 2 mg/ml by ionexchange on DEAE-Sephacel, using a step-elution procedure, and was then gel-filtered on a Sephacryl S300/Ultrogel AcA34 column equilibrated in 12.4 mM sodium phosphate/200 mM NaCl/0.5 mM EDTA, pH 7.0. The gel-filtration step removed traces of aggregates and equilibrated the protein in the buffer used for scattering experiments. A final concentration step was done using B I5 Minicon concentrators (Amicon) (Perkins and Sim, 1986) . The protein concentration (c) for solution scattering was calculated from the sample absorption at 280 nm using sequence data and the modified Wetlaufer procedure (Wetlaufer, 1962; .
Scattering data for factor I were collected using buffers containing 0.2 M NaCl, 12.5 mM sodium phosphate, with 0.1 mM, 0.5 mM or 1.0 mM EDTA, pH 7.0. For neutron experiments, samples were dialysed at 6°C into their buffers containing 0, 80 or 1000% 2H20 for at least 36 h with four changes of buffer.
For X-ray work, dialysis into 0 % 2H20 buffers was carried out likewise. The final dialysate was used for the buffer background run.
Neutron and X-ray solution scattering experiments Neutron scattering data were obtained in three independent data collection sessions on Instrument D17 at the Institut-LaueLangevin, Grenoble, France. The use of a sample-detector distance (SD) of 3.46 m and 1.40 m, a wavelength (A) of 1.106 nm and detector-main beam angles of 0°or 20 0 resulted in a Q range of 0.07-3.21 nm-1 (Q = 4ffsin0/A; 20 = scattering angle).
Other experimental neutron data collection details are given in the accompanying paper . Individual sample counting times typically ranged between 13 and 20 min in 100 % 2H20 buffers to between 50 and 200 min in 0% 2H20 buffers.
After two preliminary sessions, final X-ray scattering data were obtained in two further sessions using the low-angle solution scattering camera at Station 8.2 (Towns-Andrews et al., 1989) at the Synchroton Radiation Source, Daresbury, Warrington, U.K. Experiments were performed with beam currents in the range 128-253 mA and a ring energy of 2.00 GeV. Samples were measured for 10 min for protein concentrations that ranged between 1.0 and 4.1 mg/ml. The use of a 500-channel quadrant detector with SD values of 3.54 m and 4.16 m resulted in a usable Q range between 0.06 and 2.22 nm-u, with considerably improved signal-to-noise ratios over twice the Q range compared with the use of a linear detector in the preliminary sessions with factor I. Other details of experimental X-ray data collection are given in the accompanying paper .
Analysis of scattering data
Scattering theory in application to factor I is briefly summarized. At small Q values, analysis of the scattering curves by the Guinier equation gives the radius of gyration (RG) (which is a measure of macromolecular elongation) and the forward scattered intensity at zero Q [I(0)] (which is a measure ofcomposition) (Guinier and Fournet, 1955; Glatter and Kratky, 1982) :
This expression is valid for I(Q) values in a Q range corresponding to Q-RG values less than 1.5. Absolute or relative molecular masses (Mr) are obtained from the I(0)/c values, where c is the sample concentration (Kratky, 1963; Jacrot and Zaccai, 1981) . If one of the molecular dimensions is longer than the other two (by as little as 2: 1: 1), the radius of gyration of the cross-section RXS and the cross-sectional intensity at zero angle [I(Q) Q]QO can be obtained from the Q range beyond that used in the RG analyses (Pilz, 1982) : Hjelm (1985) has considered the analysis of macromolecules with a non-uniform cross-section along their major axis. In neutron-contrast-variation studies, the protein matchpoint (at which factor I is invisible to neutrons) was obtained from plots of v {[I(0)J/cT8t} and / ({[I(Q) Q]Q)O}/cT8t) against volume % 2H20 (T5, sample transmission; t, path length). The matchpoint was predicted from the amino acid and carbohydrate composition on the basis that the protein volume was unhydrated and there was 100% of non-exchange of the main-chain NH protons .
Since glycoproteins are inhomogeneous in their scattering densities, the RG and Rxs data depend on the solvent scattering density. This dependence is described by the Stuhrmann equation (Ibel and Stuhrmann, 1976 (Glatter and Kratky, 1982) . Alternatively, L can be calculated from the intensity ratios, where L is derived from iT*I(0)/II(Q)-Q]Q,O' and this is not dependent on the assumed shape . The two semi-axes, A and B, of the elliptical cylinder are calculated by combining the dry (neutrons) or hydrated (X-rays) volume (V) (V = TABL) with the RXS, where RXS2 = (A2+ B2)/4 for an elliptical cylinder. The hydrated volume is obtained on the basis of a hydration of 0.3 g of water/g of glycoprotein and 0.0245 nm3 per water molecule [see the accompanying paper ].
Indirect transformation of the scattering data in reciprocal space, I(Q), into those in real space, P(r), was carried out using the ITP81 program of Glatter (1982) . This offers an alternative calculation of the RG that is based on the full scattering curve, and gives the maximum dimension of the macromolecule L [for details, see the accompanying paper ]. For factor I, the neutron I(Q) contained 93 data points extending out to 3.01 nm-' and was fitted with eight splines with the maximum assumed dimension (Dmax ) set as 18.0 nm, whereas the X-ray I(Q) contained 133 data points extending out to 2.23 nm'1 and was fitted with eight splines with Dm,x set as 20.0 nm.
Modelling of the overall structure of factor I Calculations of the full scattering curves for factor I using small Debye spheres followed standard procedures (Glatter and Kratky, 1982) in application to neutron and synchrotron X-ray scattering data (Perkins and Weiss, 1983; Perkins and Sim, 1986; . To constrain the simulations, the unhydrated volume of factor I was calculated from the composition using sequence data and the assumption that all six carbohydrate sites on factor I were occupied by either high mannose or tetraantennary complex-type oligosaccharides respectively (total volumes of 92.1 nm3 or 104.1 nm3) (Chothia, 1975; . The neutron and X-ray curve-modelling procedure used was that described in the accompanying paper . The final Debye models were generated with each sphere volume set as that of the cube of side 0.54 nm (dry model) or 0.589 nm (hydrated model). Note that a good curve-fit does not lead to the determination of a unique structure as the result of the spherical averaging which is implicit in solution scattering.
Modelling of the sedimentation coefficient (s20,) was based on the hydrated volume as in the X-ray curve-fitting. The frictional coefficient (f) was calculated from:
where P20,w is the density of water at 20°C, N is Avogadro's constant, and v is the partial specific volume. The calculation of f from sphere models was performed using the program GENDIA (Garcia de la Torre and Bloomfield, 1977a,b) and the hydrated X-ray scattering model (but with non-overlapping spheres of diameter 0.589 nm), as described in the accompanying paper .
RESULTS AND DISCUSSION
Neutron scattering studies of factor I Neutron scattering was used to investigate the overall structure of factor I in ionic conditions close to physiological using 0, 80 and 100 % 2H20 buffers. A concentration range of 1.3-4.5 mg/ml gave satisfactory counting statistics (Figure la) , and no concentration effects could be detected in this range. Linear Guinier RG plots were reproducibly observed in an acceptable Q RG range between 0.3 to 1.3. Likewise linear cross-sectional Guinier RXS plots could be obtained in an acceptable Q * R., range of 0.7 to 1.2 (Figure ic) .
Analysis of the Guinier I(0) data for factor I is directly related to its composition. The total of 565 amino acid residues results in an Mr of 63300 for the protein component. For factor I, higher Mr values of 88 000-93 000 have been measured from hydrodynamic data or SDS/PAGE (Cooper, 1975; Pangburn et al., 1977; Fearon, 1977; Crossley and Porter, 1980) , and another, of M, 75000, was measured using SDS/PAGE (Hsiung et al., 1982) . The difference in Mr is attributed to carbohydrate; however, no accurate carbohydrate content is available. Pangburn et al. (1977) report that factor I is at least 10.7 % carbohydrate by weight. If six high-mannose oligosaccharide chains are present (each of assumed structure Man9GlcNAc2), these result in a final Mr of 74 500, which is 15.0 % carbohydrate (w/w). If six tetra-antennary complex-type oligosaccharide chains are present, this gives an Mr of 85300, which is 25.7% carbohydrate (w/w) and is close to the majority of biochemical determinations of the Mr. It is, however, known that high glycosylation levels in a glycoprotein lead to aberrantly high-Me values when visualized by SDS/PAGE (Gordon, 1975) . The predicted Mr values of 74500-85300 thus define an error range within which the scattering analyses were performed. (Crossley and Porter, 1980; Nagasawa et al., 1980) or 5.0 (Goldberger et al., 1984 (Perkins, 1988b) , it is seen that factor I possesses an extended solution structure. This structural anisotropy is similar to that found with the complement components C3, C4, C5 and C9 which are moderately elongated in shape Smith et al., 1992) .
The Stuhrmann analysis of the RXS data (Figure 2) Two full neutron scattering curves I(Q) in reciprocal space extending to Q = 3 nm-' were transformed into distance dis- (Glatter, 1982) based on the neutron and X-ray /(Q) data for factor I (a) The neutron P(r) curve corresponds to the solid line with statistical error bars, using a factor sample at 3.5 mg/ml measured in a negative solute-solvent contrast in a 100% 2H20 buffer.
The neutron maximum length of factor lies between 13.5 and 18 nm, based on a calculation with eight splines and D,x. set at 18 nm. (b) The X-ray P(r) curve is depicted by the continuous line; this corresponds to factor at 4.1 mg/ml in a positive solute-solvent contrast. The X-ray maximum length of factor is estimated as 15+4 nm. The broken line corresponds to the neutron P(r) curve from (a).
tribution functions P(r) in real space (Figure 3a ). The best P(r) analysis showed that the I(0) value from P(r) was within 1 % of the Guinier value, whereas the RG was 10 % larger. The statistical errors of Figure 3 (a) and the larger-than-expected RG value suggest that the maximum dimension of factor I is at least 13.5 nm and that 18 nm is the upper limit. The P(r) curve is thus consistent with the L value of 12.8 +0.8 nm from the Guinier analyses. The most frequently occurring distance within factor I is deduced from the maximum in P(r) to be at r = 3.2 nm. The neutron contrast variation aG and axs values can be compared with those for other glycoproteins after these have with the observed axs value of 11(±2) x 10-5. In terms of its average cross-sectional properties, the distribution of hydrophilic and hydrophobic residues in factor I is similar to that expected for elongated glycoproteins. The low aG of factor I is thus the result of a relatively even distribution of hydrophilic and hydrophobic residues along the longest axis of the macromolecule, as encountered for Clq of complement (Perkins et al., 1984) and also C3, C4 and C5 of complement. Synchrotron X-ray scattering studies of factor I As a corroboration of the neutron data, synchrotron X-ray scattering (corresponding to high positive solute-solvent contrasts) was used with factor I in the concentration range 1.5-4.1 mg/ml. Analyses of the ten time frames during selected sample runs showed that beam irradiation did not lead to timedependent changes in the scattering curves of factor I. Linear
Guinier RG and RXS plots within satisfactory Q RG and Q * RXS ranges were obtained (Figures lb and Id) . The Mr of factor I was determined to be 89000-78 000 (± 7000) (six determinations for c between 2.1 to 4.1 mg/ml) by reference to four other proteins of known Mr and composition measured in the same beamtime session. This calculation is within error of the neutron Mr and the two possible sequence Mr values, and shows that the data correspond to monomeric, monodisperse factor I. The mean RG was determined to be 3.96 + 0.12 nm (eight determinations), and the mean RXS was 1.64 + 0.04 nm (ten). These values are within error of the neutron RG and RXS data measured in 00% 2H20 buffers of 3.84 + 0.11 nm and 1.66 +0.03 nm.
Combination of the overall and cross-sectional X-ray Guinier analyses lead to a length (L) of 12.7 +0.6 nm from the RG and RXS data, and one of 13.9 + 0.8 nm from the ratio of intensities, which are both in good agreement with the neutron value 12.8 +0.8 nm. The molecular dimensions L x 2A x 2B of factor I were determined as 12.8 nm x 6.3 nm x 1.8 nm and 12.8 nmx6.2 nmx2.1 nm for Mr values of 74500 and 85300 respectively, of hydrated volume 122.6 nm3 and 138.9 nm3. Since the S.D.s of 2A and 2B were + 0.2 nm and + 0.1 nm respectively, these two results are within error of each other, and also agree with those of factor I by neutrons. The X-ray P(r) curve gave a maximum dimension of factor I of 15 +1 nm, which is consistent with other determinations. The maximum in the X-ray P(r) curve is at r = 3.6 nm, which is slightly larger than, but within error ( ± 0.2 nm) of, the neutron P(r) maximum at 3.2 nm. This similarity reflects the low positive value of aG observed in Figure 2 , and confirms the overall low inhomogeneity of scattering density within factor 1. Larger differences between the X-ray and neutron P(r) in Figure 3 (b) were seen only at large r, where the precision of the P(r) calculation is reduced.
Scattering curve simulations for factor I
The full neutron and X-ray scattering curves for factor I were performed twice to assess the effect of the Mr values of 74 500 and 85300. Neutron curve-fitting was initially based on a simple elliptical cylinder to assess the overall dimensions of factor I (Figure 4a ).
Sphere models were constructed to follow the RG-C of 3.83 + 0.11 nm and the approximate dimensions of 12.8 nm x 5.7 nm x (1.6-1.9 nm) (±0.8-0.2 nm) derived from the Guinier analyses. For an Mr of 74500 (volume of 92.1 nm3), the testing of 29 models showed that good fits to the 100 % and 00% 2H20 data could be obtained with a 268-sphere model (cube side 0.70 nm; volume 91.9 nm3) in an array of 19 x 8 x 2 with dimensions of 13.3 nm x 5.6 nm x 1.4 nm. This model had an RG of 3.85 nm. The goodness-of-fit (R) coefficient was acceptable at 0.020 for the 100% 2H20 curve and 0.021 for the 00% 2H20 curve. A single-density model gave good curve-fits in both contrasts, in accordance with the low Stuhrmann ax value. The relatively low Mr of factor I and the resulting poorer counting statistics for the 0% 2H20 curve did not permit an assessment of whether two-density models would give improved curve-fits. For the Mr of 85 300 (volume of 104.1 nm3), the above elliptical cylinder model was adapted by the addition of an extra segment of spheres in an array of 19 x 2 x 1 at the centre of the model to give a total of 304 spheres in place of 268 spheres. The dimensions of this model were very similar at 13.5 nm x 6.3 nm x 1.4 nm. This model had an RG of 3.96 nm. It gave good curve-fits to both the 100 % and 00% 2H20 data with goodnessof-fit parameters (R) of 0.016 and 0.022 respectively.
Further sphere models for factor I were developed to take account of its five-domain structure. Its heavy chain was divided into four segments: i.e. Lys'-Thr89 for the FIM domain and a short N-terminal segment (plus two oligosaccharide sites), Ala90-Thr'98 for the CD5 domain (plus one oligosaccharide), Gln'99-Cys237 for the first LDLr domain and Cys238-Arg321 for the second LDLr domain and a C-terminal segment. The light chain Ile322-Val565 (plus three oligosaccharides) was assigned as the SP domain. The volumes of these five segments were 16.8, 17.5, 5.3, 11.7 and 41.1 nm3 respectively. If each segment was spherical in shape (the most compact shape possible), their diameters are 3.2, 3.2, 2.2, 2.8 and 4.3 nm respectively. If these five spheres were arranged in a linear structure, the sum of the diameters corresponds to a minimum overall length of 15.7 nm (or 16.2 nm for a total volume of 104.1 nm3). Since it is more likely that the five domains are non-spherical, this minimum length of 15.7-16.2 nm would be increased if all five domains were aligned within factor I with their longest axes co-linear with the major axis of factor I. Since factor I has a length of 13 nm, this shows that the five domains in factor I cannot be arranged as a linear structure.
The SP domain was modelled starting from the ,3-trypsin sphere model in the accompanying paper and the sequence alignment in the accompanying paper . The ,3-trypsin model of 188 spheres was converted into the SP domain of factor I by adding 73 spheres. Of these, 39 spheres correspond to the three oligosaccharide chains at Asn446, Asn476 and Asn528. In the fl-trypsin crystal structure, these correspond to Gly 33, Ser167 and Ser202. All were located on the same face of the structure, away from the catalytic triad (Figure 4 ). All three were taken to be either the highmannose or the tetra-antennary complex types to correspond to the Mr values of 74500 and 85300. The remaining 34 spheres correspond to amino acid residues which were added to allow for three large sequence insertions between fl-strands D and F, H and I, M and N, and one more at the C-terminus in ,-trypsin, as well as several minor residue insertions and deletions. The factor curve (continuous line) calculated from the model shown on the right is compared with the experimental curves (0) measured at 3.5 mg/ml in a 100% 2H20 buffer and at 4.7 mg/ml in a 0% 2H20 buffer on Instrument D17. Error bars due to data-counting statistics are shown when these are large enough to be seen. is now attached to a V-shaped structure which represents the four remaining domains. A total of 668 spheres (diameter 0.54 nm) was used for a total Mr of 85300.
order for a total volume of 92.1 nm3, and 131, 124, 34, 74 and 299 for a total volume of 104.1 nm3. In one class of neutron models, factor I was considered as the association of the SP domain with an elliptical cylinder for the remaining FIM, CD5, LDLr-1 and LDLr-2 domains. For the Mr of 74 500 (volume 92.1 nm3), the elliptical cylinder was composed of 323 spheres. Testing showed that the most satisfactory curve fit resulted from an array of 14 x 8 x 3 spheres (7.6 nm x 4.3 nm x 1.6 nm in size), totalling 585 spheres in all (Figure 4b ). This resulted in an RG value of 3.72 nm. The R coefficient of the curvefits was acceptable at 0.022 for the 100% 2H20 data and 0.021 for the 0% 2H20 data. For the Mr of 85 300 (volume 104.1 nm3), an array of 13x9x3 spheres (7.0nmx4.9nmxl.6nm) gave the best fit with a total of 652 spheres. This gave an RG value of 3.77 nm. The R coefficients of the curve-fits were good at 0.015 for the 100% 2H20 data and 0.022 for the 0% 2H20 data.
In a second class of neutron models, factor I was considered as the association of the SP domain with a V-shape for the other domains. The first arm was constructed from 108 spheres (the two LDLr domains) and the second arm contained 217 or 255 spheres (the FIM and CD5 domains). For the Mr-74 500 model, trial-and-error calculations showed that the most satisfactory curve-fits were obtained with an inter-arm angle of 10°, and that the two arms were best set as arrays of 14 x 4 x 2 and 18 x 4 x 3 spheres. The final model contained 590 spheres (volume 92.9 nm3), and had an RG value of 37.8 nm. The R coefficients of the curve-fits were good at 0.015 for the 100% 2H20 data and 0.021 for the 0% 2H20 data. For the Mr-85 300 model, the best curve-fit was obtained with arrays of 14 x 4 x 2 and 17 x 3 x 5 spheres. This model contained 668 spheres (105.2 nm3), and led to an RG value of 3.87 nm. The R coefficients of the curve-fits were also good at 0.011 for the 1000% 2H20 data and 0.023 for the 00% 2H20 data.
For comparison with the X-ray scattering curves, the neutron models were hydrated assuming 0.3 g of water/g of glycoprotein.
Good curve-fits in the Q ranges corresponding to the RG Guinier fits were obtained out to a Q of 0.4 nm-1 (results not shown). The curve-fits deteriorated in the RXS region of the scattering curve, which was contrast-sensitive in the neutron experiments ( Figure  2 ). This discrepancy was thus attributed to the high (15.0-25.7 %) carbohydrate content of factor I, since carbohydrate residues are electron-rich and make a relatively large contribution to X-ray scattering curves.
Simulations of hydrodynamic data for factor I Hydrodynamic sedimentation data serve as an independent control of the structure of factor I. The sedimentation coefficient (s°0 W) of factor I has been reported to be 4.5 S at I0.15 (Cooper, 1975) . On the basis of the M, values of 74500 and 83500, the calculated hydrated v of factor I for sO0 analyses is 0.714 ml/g and 0.708 ml/g respectively . From hydrated volumes of 122.6 nm3 or 138.9 nm3, frictional ratios (f/f0) of 1.36 or 1.52 were determined.
Hydrodynamic spheres were used to calculate the value of s0, w directly from the hydrated-sphere model used for X-ray modelling. The ellipsoid, SP/ellipsoid and SP/V-shape models ( Figure   4 ) gave predicted s°0, values of 4.9 S, 4.6 S and 4.3 S in that order for the 92.1 nm3 model. The°0 o2 values were 5.5 S, 4.8 S and 4.7 S respectively for the 104.1 nm3 model. Since the precision of the experimental data is usually considered to be + 0.3 S (Perkins, 1989) , the second and third types of models are seen to be fully compatible with the experimental s°o, value of 4.5 S, irrespective of the presumed M, for factor I, while the agreement for the ellipsoid model is at the limit of error. These agreements support the dimensions determined for factor I from the scattering analyses.
CONCLUSIONS
Factor I has a multidomain structure like many other complement proteins. The present study shows that its overall dimensions are not compatible with a fully extended arrangement of the five domains in solution. The overall length of factor I has been determined four times [from the Guinier data, P(r) analyses, scattering and hydrodynamic modelling] to be close to 13-14 nm. The scattering model of factor (sphere diameter 0.54 nm) is shown in comparison with its cofactor complement component C4BP (sphere diameter 1.0 nm) and one of its substrates C4 (sphere diameter 0.8 nm) . It should be noted that other scatteringequivalent models can offer equally satisfactory curve-fits to the data, and that the general form of these structures should not be over-rated.
It is gratifying that DiScipio (1992) independently reported a length of 13 nm by electron microscopy for factor I after we had completed the present study. A linear extended arrangement of factor I domains would be at least 15-16 nm in length, and would most probably be longer. Most of the other complement proteins studied so far possess extended domain structures (Clq, CIr, CIs, C1 inhibitor, C4BP, factor H and properdin) . C9 is the only other complement protein studied by scattering to date to possess a non-extended domain structure (Smith et al., 1992 ). The explicit consideration of possible domain arrangements in factor I was much assisted by the ability to model the largest one of the five in the light chain with spheres using its structural homology with fl-trypsin. The two obvious possible arrangements for the four domains in the heavy chain are a zig-zag conformation with the long axes of the small domains arranged sideby-side (Figure 4b ) or a V-shaped structure (Figure 4c ). It is reasonable to expect that the FIM, CD5 and two LDLr domains are about 4 rm x 2 nm x 2 rm in size, by analogy to the short complement/consensus repeat in C4BP and the thrombospondin repeat in properdin Smith et al., 1991) . A zig-zag conformation of four domains would be readily accommodated within the dimensions of 7-8 nm x 4-5 nm x 2 nm (Figure 4b ). Alternatively a V-shaped structure would correspond to two LDLr domains of size about 8 nm x 2 nm x 2 nm located in the arm attached to the SP domain, and a pair ofFIM and CD5 domains of size about 10 nm x 2 nm x 2 nm in the other arm (Figure 4c) . It is not possible to discriminate between either of these possibilities by scattering, as they are equivalent in scattering. The electron-microscopic images obtained by DiScipio (1992) also do not distinguish between either ofthese possibilities. There, a bilobal structure with an overall length of 13.0 + 1.4 nm and lobes of 4.9 +0.9 nm and 5.4+0.8 nm in diameter was observed, in which one lobe may be V-shaped in appearance. We have attempted to model factor I with two solid lobes joined by a linker of various lengths and sizes, but the curve-fits were not promising. It can nonetheless be concluded that factor I does not contain an extended linear conformation of domains. Structural studies at higher resolution will be required to determine more precise details.
Irrespective of the packing arrangement of the domains in factor I, the present study implies that the domains are arranged in such a way that steric factors will be important for functional activity. It is possible that direct interaction of factor I with a cofactor protein or with the C3b/C4b cofactor complex causes a change in exposure of the reactive-site region. A comparative view of these low-resolution structures is shown in Figure 5 . It is not possible to predict from the modelling if the active site of the SP domain would be sterically masked by the domains in the elliptical cylinder or V-shaped segments in Figures 4(b) 
